25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33742146 | Kinome-wide analysis of the effect of statins in colorectal cancer. | 2021 Jun | 1 |
2 | 31662972 | Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells. | 2019 | 1 |
3 | 28968593 | GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors. | 2018 | 1 |
4 | 29207042 | Anti-inflammatory effect of lovastatin is mediated via the modulation of NF-κB and inhibition of HDAC1 and the PI3K/Akt/mTOR pathway in RAW264.7 macrophages. | 2018 Feb | 1 |
5 | 26931464 | Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity. | 2016 May 15 | 7 |
6 | 25569448 | Blockade of the Ras/Raf/ERK and Ras/PI3K/Akt Pathways by Monacolin K Reduces the Expression of GLO1 and Induces Apoptosis in U937 Cells. | 2015 Feb 4 | 3 |
7 | 26208883 | Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase. | 2015 Nov | 2 |
8 | 26636335 | Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways. | 2015 | 2 |
9 | 23764197 | The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy. | 2013 Sep | 1 |
10 | 21258249 | Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. | 2011 Mar | 2 |
11 | 21624609 | Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells. | 2011 Jun | 1 |
12 | 21660955 | Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. | 2011 Sep | 1 |
13 | 19760159 | Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations. | 2010 Dec | 2 |
14 | 20562912 | Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins. | 2010 Aug 19 | 3 |
15 | 20838437 | Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. | 2010 Sep 3 | 4 |
16 | 19417733 | Lovastatin restores the function of endothelial progenitor cells damaged by oxLDL. | 2009 May | 2 |
17 | 19787257 | Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. | 2009 Nov | 1 |
18 | 18376053 | Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways. | 2008 Mar | 2 |
19 | 17050804 | Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment. | 2007 Jan | 1 |
20 | 17158337 | Critical role for FoxO3a-dependent regulation of p21CIP1/WAF1 in response to statin signaling in cardiac myocytes. | 2007 Jan 5 | 1 |
21 | 17179158 | Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. | 2007 Feb 16 | 1 |
22 | 17472962 | Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. | 2007 Jul 6 | 1 |
23 | 16968805 | Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. | 2006 Nov | 1 |
24 | 15788691 | Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. | 2005 Mar 15 | 1 |
25 | 15953363 | Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. | 2005 Jul | 4 |